David Reese

David M.
Reese was the founder of Translational Oncology Research International, Inc., founded in 2003, where the title held was President & Chief Medical Officer from 2003 to 2005.
Current jobs include Chief Executive Officer at KAI Pharmaceuticals, Inc.; President & Director at Alantos Pharmaceuticals Holding, Inc.; President & Director at BioVex Group, Inc.; Director at CEO Roundtable on Cancer, Inc.; and Director at Research!America starting in 2023.
Former jobs include Chief Executive Officer at Onyx Pharmaceuticals, Inc., ChemoCentryx, Inc., and Five Prime Therapeutics, Inc.; Director-Clinical Research at Translational Research In Oncology; Director-Clinical Research at Breast Cancer International Research Group Ltd. from 2001 to 2003; and Chief Technology Officer & Executive Vice President at Amgen, Inc. from 2023 to 2026.
Education includes undergraduate studies at The University of Cincinnati College of Medicine and Harvard College.